News about technology, money, and decisions shaping how long people live

Joined October 2025
HackAging.ai retweeted
🚨 Anthropic is looking to acquire companies in AI x bio I inferred this from a fresh job posting that literally describes their strategy. They want someone who can 'structure and negotiate complex deals' and 'tell a durable AI-native business from a thin wrapper.' From the terms they use ('tuck-in acquisitions', 'acquihires'), we can tell that they're targeting rather small and medium-sized teams. But we can't be 100% sure here, because a decacorn looks kind of small next to a juggernaut aiming for a $2 trillion IPO. Named target areas: drug discovery, clinical development, regulatory and medical writing, lab automation, healthcare data infrastructure.
15
31
14
264
46,433
HackAging.ai retweeted
Our longevity biotech deep dive for Social Capital crossed 350k views (way more than we anticipated). The full report is private. For investors looking at longevity biotech, here are two bets worth understanding: 1) The overcrowded bet: cellular reprogramming. Bezos, Altman, and Brian Armstrong went in early, and NewLimit just raised $435M from tier-1 VCs and Eli Lilly - a genuinely bullish signal. Still, only two studies show a lifespan gain in normal mice (7-12%), so don't expect systemic rejuvenation from the first generation of epigenetic reprogramming therapies, but they'll very likely show efficacy against specific diseases. It might not be too late to enter the field, but it's definitely not early: three companies with only preclinical data are already at unicorn valuations. 2) The asymmetric bet: growing and preserving organs. Today up to 75% of donated hearts and lungs are wasted because they last only hours outside the body, and globally just ~10% of the need is met. The companies fixing that, building new organ sources and learning to bank them long-term, are early, and many are still in stealth. We personally know who's building what, and it's still possible to get in at low valuations. That's where the alpha is hidden. For the @chamath's @socialcapital deep dive, we assembled a group of 17 leading scientists, founders, and experts. Much of the useful signal is offline: who’s building in stealth, which founders can actually deliver, and which science is real versus merely well-promoted. With that work finished, we now have capacity for the next longevity biotech project for a family office, fund, private banking team, or private investor looking at the field. Beyond deep dives, we can help you source stealth deals, run due diligence, build custom intel tools, or launch client-facing longevity products. Know someone who runs a family office or fund and is into longevity? Share this with them. Want details? Let's jump on a quick call - DM.
11
15
3
64
3,788
HackAging.ai retweeted
Sputnik moment!! Russia is creating the world's first state-recognized longevity doctor role, effective Sep 1, 2026. What state recognition unlocks: - longevity departments in top medical schools - dedicated institutes and clinics - standardized diagnostic & therapeutic protocols - indications insurers and pharma can actually reimburse - derisked capital (the field out of the grey zone) - (most importantly) longer healthier lives How are the US, EU, and everyone else still behind?
8
17
1
84
8,483
HackAging.ai retweeted
Great pod, but these four facts about longevity need correction: 1) "Longevity Escape Velocity" was coined by mighty @aubreydegrey, not Diamandis. @PeterDiamandis did a great job popularizing it 2) "Multiple clinical trials" for epigenetic reprogramming? There's exactly one: @lifebiosciences Phase 1 that is just kicking off. Everything else is preclinical 3) There is no public data on Altos Labs raising $10B. Most sources claim $3B, with @PitchBook showing $5B. Still massive though 4) "250 human year equivalent" mouse claim has no published support. Epigenetic reprogramming has notoriously bad track record in mice lifespan extensions. Best result: ~7% total lifespan extension by Rejuvenate Bio and original Ocampo's 30% (but in progeria mice) Directionally though @DavidFriedberg is right. Epigenetic reprogramming is very exciting and promising. Just don't oversell it, the subfield has enough hype already. Also (this is very important) David's optimism might give the impression that we are close to solving aging, but it is not true. Progress is slow and field is drastically underfunded. @ChrisWillx great work, great guest - I enjoyed this episode a lot!
Unstoppable. New episode now live with @friedberg
10
8
90
6,665
HackAging.ai retweeted
Our friends are launching Fund Longevity and taking longevity advocacy to the streets. 📍 one of 16 cities or online! 📣 spread the word! @LinusPeters @vladileshko @longevitynastya
3
9
26
736
HackAging.ai retweeted
I tracked every billionaire who died in the last decade. 389 deaths. $2.17 trillion in wealth. 6 helicopter crashes. Here's what I found.
87
392
62
2,448
305,818
HackAging.ai retweeted
Article on @HackAgingAI hackathon
Hackaging.ai co-organizer Alexey Strygin on breaking through the field’s bottlenecks and inspiring new innovators via a global AI hackathon. longevity.technology/news/ar… #longevity #AI #biotech #aging #innovation #hackathon
3
4
19
1,656
✨ Excited to have won the @HackAgingAI Agentic AI Against Aging hackathon's Rapid Adoption track, with our #ECMAgingAtlas — built using an agentic framework for bespoke data ingestion and processing. Grateful to the team — @DanielKravtsov and Bob Walsh!
Agentic AI vs Aging Hackathon Make an impact or shift your career into longevity with @RetroBio_, @hacking_aging, @nebiusai, @BioProtocol, @athena_DAO_, @vita_dao Turn two weeks into a job, collaboration, or company. Details 🧵👇
2
3
1
9
575
HackAging.ai retweeted
join our open talk with @MartinBJensen 24 Oct 1 PM PT / 22 CET Zoom/Youtube live
What should we work on in longevity? The biggest bottlenecks? Highest impact areas? Join @MartinBJensen breaking down @NornGroup’s refreshed Big Picture, a strategic roadmap for maximizing progress in longbio. Online Talk + Q&A 📅 Oct 24 ⏰ 1 PM PT / 22 CET 👇
3
8
786
Our hackathon "Agentic AI Against Aging" has begun Let’s figure out what "agentic AI" in its title means: what (or whom!) are we going to put in the ring against aging? Just in case: what is AI? Simple—in this context, it means neural networks, mainly LLMs. Now to the most interesting part: what is agency? It is an agent’s ability to freely choose a desired goal, the means of achieving it, and, ultimately, to achieve it. The first thing to understand about agency is that it is a spectrum. A spectrum of how much an agent’s goals are truly its own, how free it is in choosing the means and paths to achieve those goals, and how persistent and adaptive it can be. We assume that the AI agents we will build do not have goals of their own, and will do what we tell them. So in this regard they do not have agency. And what about freedom in choosing the means and paths to achieve goals? In this sense, AI already has agency: - We can give an LLM various tools—for example, web search or a RAG knowledge base—and the freedom to choose when and how to use them, as well as whether to use them at all. - At the system prompt level, we can avoid prescribing a specific way to perform tasks and leave the LLM the option to decide on its own how to handle the task. So, strictly speaking, there are easy ways to increase a neural net’s agency, but those who have used them a lot know this doesn’t always help. Often, on the contrary, you need to spell out in maximum detail what exactly the model should do, in what sequence, and how, to achieve the optimal result. That is, sometimes we take agency away from AI to improve the outcome :) But agency truly manifests in multi-agent systems consisting of agents that can decide which next agent to hand off a task or subtask to. Then the system’s behavior evolves from a simple pipeline—where all the steps of solving the task are predefined—into something indeterminate that will “think” not only about the task, but also about the very process of solving it: the type of the next step and how many steps there should be. And with proper tuning, this gives rise to persistence, adaptability, and goal-directedness: the system can try and err, draw conclusions and try again, seek alternative paths, and work as long as necessary until the task is solved. In theory. But in practice, people often call plain LLMs with a system prompt “agents,” even if their capabilities are highly deterministic. And “multi-agent systems” are pipelines or architectures composed of such “agents.” That does not prevent such multi-agent systems from being a very powerful tool if you know what you want and how the step-by-step process of solving your task should look.
1
5
319
Agentic AI vs Aging Hackathon Make an impact or shift your career into longevity with @RetroBio_, @hacking_aging, @nebiusai, @BioProtocol, @athena_DAO_, @vita_dao Turn two weeks into a job, collaboration, or company. Details 🧵👇
69
69
38
317
95,696